Opportunity Information: Apply for RFA RM 18 018

The National Institutes of Health (NIH) funding opportunity titled "Somatic Cell Genome Editing Dissemination and Coordinating Center (U24 Clinical Trial Not Allowed)" (Funding Opportunity Number RFA-RM-18-018) supports the creation of a central Dissemination and Coordination Center (DCC) for the NIH Somatic Cell Genome Editing (SCGE) Consortium. This is a discretionary health-related program (CFDA 93.310) using a cooperative agreement mechanism (U24), which generally means NIH expects substantial involvement in coordinating and guiding activities alongside the awardee rather than operating as a hands-off funder. The opportunity was posted on January 24, 2018, with an original closing date of April 3, 2018. As stated in the title and announcement, clinical trials are not allowed under this award.

The main purpose of the DCC is to act as the organizational and communications hub for a larger, multi-part consortium focused on advancing somatic cell genome editing. Alongside the DCC, the SCGE Consortium includes four major scientific components: (1) genome editing tools, (2) delivery systems, (3) animal models, and (4) biological assays. The consortium model is designed to accelerate progress by sharing expertise, data, methods, and research tools across these groups so that the field ends up with validated techniques and broadly usable knowledge rather than isolated, one-off advances.

Within this structure, the DCC is expected to actively interact with all other consortium components to make collaboration practical and efficient. That coordination role includes facilitating cross-team communication, helping align shared goals and deliverables, and ensuring that outputs produced in one area (for example, a delivery approach or an assay) can be understood, compared, and reused by others. A central expectation is that the DCC will develop and maintain an online platform that supports information sharing within the consortium, serving as a common space for distributing updates, resources, and other materials needed for joint work.

A second major responsibility is resource integration and packaging. The DCC must assemble tools, methods, data, and best practices generated across all consortium components into a coherent "genome editing toolkit." In practical terms, this means organizing consortium outputs so they are findable and usable, not just stored. The emphasis is on validated and well-documented resources, implying attention to standardization, clear descriptions of how tools were produced and tested, and guidance on appropriate use. Beyond serving the internal consortium, the DCC is also responsible for broader dissemination: distributing the toolkit and other appropriate resources to researchers across the wider biomedical research community to help speed adoption and reduce duplicated effort.

Eligibility is broad and includes many common applicant types such as state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The announcement also explicitly highlights additional eligible applicant categories, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, Indian/Native American tribal governments other than federally recognized entities, and U.S. territories or possessions.

At the same time, the opportunity places clear limits on foreign participation. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply as the applicant organization. However, "foreign components" as defined in the NIH Grants Policy Statement are allowed, meaning a U.S.-based applicant may include certain foreign elements in the overall project when justified and structured in compliance with NIH policy, even though a foreign institution cannot serve as the primary applicant.

In short, this FOA funds a U24 cooperative agreement to build and operate the communications, coordination, and dissemination backbone of the NIH SCGE Consortium. The DCC is expected to connect multiple technical and scientific groups, create an online collaboration platform, convert distributed consortium outputs into a structured genome editing toolkit, and push those resources outward to the broader research community, all while staying within a non-clinical-trial scope and adhering to NIH eligibility rules regarding domestic applicants and allowable foreign components.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Somatic Cell Genome Editing Dissemination and Coordinating Center (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.310.
  • This funding opportunity was created on 2018-01-24.
  • Applicants must submit their applications by 2018-04-03. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA RM 18 018

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: BRAIN Initiative: New Concepts and Early - Stage Research for Large - Scale Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)

Previous opportunity: Sleep disorders and circadian clock disruption in Alzheimers disease and other dementias of aging (R01 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA RM 18 018

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA RM 18 018) also looked into and applied for these:

Funding Opportunity
Alzheimer's Disease Research Centers (P30 - Clinical Trials Not Allowed) Apply for RFA AG 19 001

Funding Number: RFA AG 19 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,000,000
Expanding the Human Genome Editing Repertoire (U01 Clinical Trial Not Allowed) Apply for RFA RM 18 017

Funding Number: RFA RM 18 017
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
The Human BioMolecular Atlas Program (HuBMAP) Integration, Visualization and Engagement (HIVE) Initiative (OT2 Clinical Trials Not Allowed) Apply for RFA RM 18 001

Funding Number: RFA RM 18 001
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required) Apply for PAR 18 595

Funding Number: PAR 18 595
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R41/R42 - Clinical Trials Optional) Apply for PAR 18 587

Funding Number: PAR 18 587
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R43/R44 - Clinical Trial Optional) Apply for PAR 18 588

Funding Number: PAR 18 588
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 18 594

Funding Number: PAR 18 594
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clincal Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) Apply for PAR 18 597

Funding Number: PAR 18 597
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) Apply for PAR 18 596

Funding Number: PAR 18 596
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Coordination Center for Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (U24 Clinical Trial Not Allowed) Apply for RFA HL 19 001

Funding Number: RFA HL 19 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $320,000
Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed) Apply for RFA HL 19 002

Funding Number: RFA HL 19 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Methods Development in Natural Products Chemistry (R41/R42 Clinical Trial Not Allowed) Apply for PAR 18 608

Funding Number: PAR 18 608
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Methods Development in Natural Products Chemistry (R43/R44 Clinical Trial Not Allowed) Apply for PA 18 607

Funding Number: PA 18 607
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R43/R44 Clinical Trial Not Allowed) Apply for PA 18 610

Funding Number: PA 18 610
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required) Apply for PA 18 613

Funding Number: PA 18 613
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINDS Exploratory Clinical Trials for Small Business (R44) - Clinical Trial Required Apply for PAR 18 618

Funding Number: PAR 18 618
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINDS Exploratory Clinical Trials for Small Business (R42) - Clinical Trial Required Apply for PAR 18 617

Funding Number: PAR 18 617
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed) Apply for PA 18 614

Funding Number: PA 18 614
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R41/R42 Clinical Trial Not Allowed) Apply for PA 18 609

Funding Number: PA 18 609
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Disease Mechanisms of Prenatal and Pediatric Hydrocephalus (R01 Clinical Trial Not Allowed) Apply for PA 18 622

Funding Number: PA 18 622
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA RM 18 018", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: